Alimera Sciences Announces 23 Clinical Presentations and a Sponsored Symposium at 16th EURETINA Congress
/
Date06 Sep 2016
ATLANTA, Sept. 06, 2016 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced... Read More →
XOMA to Host XOMA 358 Clinical Update Webcast and Conference Call on September 15, 2016
/
Date06 Sep 2016
BERKELEY, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today it will... Read More →
RAPS' New Book Offers 36 Articles on Eclectic Science Topics for Curious Readers
/
Date06 Sep 2016
ROCKVILLE, Md., Sept. 6, 2016 (GLOBE NEWSWIRE) — The Regulatory Affairs Professionals Society (RAPS) has just published a new book that offers curious readers a... Read More →
BioMarin Announces Update to Brineura™ (Cerliponase Alfa) Program for Treatment of CLN2 Disease, a Form of Batten Disease
/
Date06 Sep 2016
Additional Data Submitted to BLA following FDA Request, PDUFA Action Date Extended to April 27, 2017 Additional 8 Months of Treatment (81-Week Data) Show Maintenance... Read More →
Stripes(R) Convenience Stores Announces Third Annual In-Store Campaign and Alliance with MD Anderson Children's Cancer Hospital
/
Date06 Sep 2016
DALLAS, Sept. 6, 2016 (GLOBE NEWSWIRE) — For the third consecutive year, Stripes® Convenience Stores is kicking off its annual campaign Sept. 7 with The... Read More →
Sonendo® to Present at the Baird 2016 Global Health Conference
/
Date06 Sep 2016
LAGUNA HILLS, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) — Sonendo®, Inc. the developer of a breakthrough technology for the endodontic marketplace, announced today that Bjarne... Read More →
Global Blood Therapeutics Joins Sickle Cell Disease (SCD) Coalition in Support of SCD Community with Goal to Improve Treatment and Care
/
Date06 Sep 2016
SOUTH SAN FRANCISCO, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment of... Read More →
Navient Foundation contributes $6,000 to Nemours Foundation to support children’s hospital and sponsor upcoming radiothon event
/
Date06 Sep 2016
WILMINGTON, Del., Sept. 06, 2016 (GLOBE NEWSWIRE) — The phones will ring off the hook at Nemours/Alfred I. DuPont Hospital for Children, as the local... Read More →
Aquinox Pharmaceuticals Initiates Patient Dosing in LEADERSHIP 301 Phase 3 Clinical Trial of AQX-1125 in Interstitial Cystitis/Bladder Pain Syndrome
/
Date06 Sep 2016
VANCOUVER, British Columbia, Sept. 06, 2016 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease... Read More →
NPSF Lucian Leape Institute Announces Program for 9th Annual Forum & Keynote Dinner
/
Date06 Sep 2016
BOSTON, Sept. 6, 2016 (GLOBE NEWSWIRE) — The National Patient Safety Foundation’s Lucian Leape Institute has announced the speakers and agenda for its 9th annual... Read More →